about
Drugs and pacemakers for vasovagal, carotid sinus and situational syncopeDrugs and pacemakers for neurally mediated reflex syncopeDrugs and pacemakers for neurally mediated reflex syncopeBradyarrhythmias.Dizziness and syncope in adolescence.Syncope in childhood.Nitrate stimulated tilt table testing: a review of the literature.New approaches to the treatment and prevention of neurally mediated reflex (neurocardiogenic) syncope.Current Management of Syncope: Treatment Alternatives.Diagnostic value of nitrate stimulated tilt testing without preceding passive tilt in patients with suspected vasovagal syncope and a healthy control group.A patient responding to combined therapy with pirmenol and midodrine for refractory neurally mediated syncope complicated by prostatic hypertrophy.When the heart is stopped for good: hypotension-bradycardia paradox revisited.Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study.Fainting attacks in children.Beta blockade in neurocardiogenic dysfunction: results of a clinical study.The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond.Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.Angiotensin II feedback is a regulator of renocortical renin, COX-2, and nNOS expression.
P2860
Q24235975-D19497DA-778E-4865-A489-3B7EB21E1B9FQ24242194-A7093057-0760-4494-9105-4AB8C1653B84Q24250093-BBF9510A-811F-4A89-A010-6EB24CB1D3DAQ33146549-37C3A2DE-4116-4EF8-A3B5-C2C2DB7180A9Q33146724-58FA09F4-FD49-40CB-B5C5-1B925433FA8CQ33148724-1A69160E-8E8C-4328-8200-001F798843A0Q33149235-3F9BA7D7-4004-41A7-9CAA-E0B281B70049Q33151677-82F1910B-1C9B-4884-8E4B-B12B62335BF5Q33151709-822C90E8-A11A-433E-ACED-E3E059E93AC2Q33152261-2B2E4435-28FD-40D8-84FD-7FD6516AE7FCQ33152352-26E33ECB-AF3D-4D75-BE54-6C0646C7280CQ33152359-3A749207-B969-48DE-BD83-669C38B98E81Q33153736-A4BA5508-D538-4594-8360-3A04E293A2ADQ33160175-FE51FAD1-931B-4BFD-91F6-91D6E1BE72FCQ33165320-1A0D3A4B-3EA6-4A8B-881A-4D7D31E8D485Q36404275-B49D60C1-D059-4615-9ECD-95627875F527Q36916953-83308279-B096-4429-84DC-1016F7CF1149Q43993532-19813E2E-2BEC-4ED7-9C5D-D53BDF4C3786
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Pharmacotherapy of neurally mediated syncope.
@ast
Pharmacotherapy of neurally mediated syncope.
@en
type
label
Pharmacotherapy of neurally mediated syncope.
@ast
Pharmacotherapy of neurally mediated syncope.
@en
prefLabel
Pharmacotherapy of neurally mediated syncope.
@ast
Pharmacotherapy of neurally mediated syncope.
@en
P2093
P1433
P1476
Pharmacotherapy of neurally mediated syncope.
@en
P2093
P304
P356
10.1161/01.CIR.100.11.1242
P407
P577
1999-09-01T00:00:00Z